1973
DOI: 10.1620/tjem.109.41
|View full text |Cite
|
Sign up to set email alerts
|

Fucosidosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
8
0

Year Published

1974
1974
2005
2005

Publication Types

Select...
7
3

Relationship

1
9

Authors

Journals

citations
Cited by 29 publications
(8 citation statements)
references
References 1 publication
0
8
0
Order By: Relevance
“…However, research is in progress to avoid the cleavage of C-terminal arginine. Studies on the physiology of NGF and with rhNGF in animal models indicated the bene¢cial e¡ects of exogenous NGF for the treatment of age dependent neuronal dysfunction [32^35] or peripheral neuropathic diseases [36,37] in humans.…”
Section: Discussionmentioning
confidence: 99%
“…However, research is in progress to avoid the cleavage of C-terminal arginine. Studies on the physiology of NGF and with rhNGF in animal models indicated the bene¢cial e¡ects of exogenous NGF for the treatment of age dependent neuronal dysfunction [32^35] or peripheral neuropathic diseases [36,37] in humans.…”
Section: Discussionmentioning
confidence: 99%
“…About one hundred cases of fucosidosis and genomic analyses have been reported worldwide (8)(9)(10)(11). The present patient was diagnosed with type III fucosidosis based on her characteristic skin rash.…”
mentioning
confidence: 80%
“…Eight cases have been reported in children: two by Durand et al (1966), Durand, Philippart, Borrone, Della Cella, and Bugiani (1967), Durand, Borrone, and Della Cella (1969a), Durand, Phillipart, Borrone, and Della Cella (1969b), one by Loeb et al (1969b and c), one by Freitag et al (1971b), Voelz, Tolksdorf, Freitag, and Spranger (1971), two siblings, patients of Dr Donnell of Los Angeles, reported by Zielke, Veath, and O'Brien (1972), one in Japan by Matsuda, Arashima, Anakura, Ege, and Hayata (1973), and one by Borrone, Gatti, Trias, and Durand (1974).…”
Section: Clinical Featuresmentioning
confidence: 99%